Two antiviral drugs are available in Australia, but one is prescribed more routinely. Here’s what you need to know as we navigate the eighth COVID wave.
How are people with long COVID faring two years after their initial infection? Many have recovered. Some still struggle with symptoms – this is more likely for those who were initially hospitalised.
While there are still far more questions than answers about long COVID-19, researchers are beginning to get a clearer picture of the health and economic consequences of the condition.
Analysis of Victoria’s winter COVID wave found Paxlovid and Lagevrio reduced the risk of hospitalisation and death. The results were better for Paxlovid, but not everyone can take it.
Technique matters when it comes to getting a sufficient amount of virus for a rapid test.
Images By Tang Ming Tung/Digital Vision via Getty Images
Rapid tests can be an incredibly useful tool for early detection of COVID-19. Unfortunately, they sometimes leave people with more questions than answers.
We hear a lot about drug-resistant bacteria. The same thing can happen with viruses.
President Joe Biden tested positive for COVID-19 on July 21, 2022, but was reportedly feeling well enough to work and take calls, as seen in this photo released by the White House.
Adam Schultz/The White House via AP
According to a letter from Biden’s doctor, the president has a runny nose, mild fatigue and a slight cough. The letter also noted that Biden began taking an antiviral drug the morning he tested positive.
The effects of COVID and a new treatment for it are leaving a bad taste in the mouth for many. How do we detect what’s salty, sweet, bitter, sour or umami?
Paxlovid may help prevent severe illness in patients at highest risk for COVID-19 complications.
picture alliance/picture alliance via Getty Images
An infectious disease doctor discusses the use, benefits and availability of a drug to prevent severe COVID-19.
Over the past couple of decades there has been a shift away from upholding patient autonomy to prioritizing public health.
Terry Vine/DigitalVision via Getty Images
Just as access to vaccines was vastly more difficult for low-income countries, the same is now true for the virus’ treatments: at potentially great cost to the world.